Antibodies are an important defense against SARS-CoV-2, but the virus continues to evolve ways to evade them. Now, ...
Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants ...
The release of Dr. Anthony Fauci's pandemic diaries has rekindled the debate over the origins of SARS-CoV-2. Here's how scientists have weighed in.
We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
New research from UNC Charlotte's Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) has found that the two most prevalent strains of the virus that cause ...
The U.S. Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine establish an ad hoc committee to review the diagnosis, treatment, and prognosis of ...
Two of the closest known relatives to SARS-CoV-2 — a pair of bat coronaviruses discovered by researchers in Laos — may transmit poorly in people despite being genetically similar to the ...
BA.3.2 spread internationally after first being identified in South Africa in November 2024, with detections rising from September 2025 and reports from at least 23 countries by 11 February 2026. U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results